Pyrazolo[4,3-c]isoquinolines as potential inhibitors of NF-kappaB activation.
Mortier J, Frederick R, Ganeff C, Remouchamps C, Talaga P, Pochet L, Wouters J, Piette J, Dejardin E, Masereel B.
Mortier J, et al.
Biochem Pharmacol. 2010 May 15;79(10):1462-72. doi: 10.1016/j.bcp.2010.01.007. Epub 2010 Jan 21.
Biochem Pharmacol. 2010.
PMID: 20096267